Prevalence of inflammatory markers (high-sensitivity C-reactive protein, nuclear factor-κB, and adiponectin) in Indian patients with type 2 diabetes mellitus with and without macrovascular complications

Metabolic Syndrome and Related Disorders

Volumn 10, Issue 3, 2012, Pages 209-213

  Misra, Durga Prasanna ^a   Das, Sidhartha ^a   Sahu, Pratima Kumari ^a  

^a SCB Medical College and Hospital   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN A1C; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPID;

ADULT; ARTICLE; BODY MASS; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC ANGIOPATHY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; LIPID BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADIPONECTIN; AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INDIA; INFLAMMATION; INFLAMMATION MEDIATORS; LIPIDS; MALE; MIDDLE AGED; NF-KAPPA B; PREVALENCE;

EID: 84861746187     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2011.0044     Document Type: Article

References (18)

1. Das S. Macrovascular disorders in diabetes: Determinants and risk factors. In: Tripathy BB (ed), RSSDI Textbook of Diabetes Mellitus, 2nd ed., vol. 2 The National Book Depot; 2008: 863-870.
2. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004;27: 813-823. (Pubitemid 38280558)
3. Devaraj S, Dasu MR, Jialal I. Diabetes is a pro-inflammatory state: A translational perspective. Expert Rev Endocrinol Metab 2010;5:19-28.
4. Shanmugam N, ReddyMA, Guha M, et al. High glucoseinduced expression of proinflammatory cytokine and chemokine genes in monocytic cells. Diabetes 2003;52: 1256-1264. (Pubitemid 36523365)
5. Dandona P, Aljada A, Chaudhuri A, et al. Metabolic syndrome. A comprehensive perspective based on interactions between obesity, diabetes and inflammation. Circulation 2005;111:1448-1454. (Pubitemid 40396812)
6. Kawano J, Arora R. The role of adiponectin in obesity, diabetes and cardiovascular disease. J Cardiometab Syndr 2009;4:44-49.
7. Schiekofer S, Andrassy M, Chen J, et al. Acute hyperglycemia causes intracellular formation of CML and activation of ras, p42/44 MAPK and nuclear Factor kB in PBMCs. Diabetes 2003;52:621-633. (Pubitemid 36323567)
8. Dr Thomas Gilmore. NF-kB transcription factors. Available at www.bu.edu/nf-kb/. Accessed January 15, 2012.
9. Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986;46:705-716. (Pubitemid 16020062)
10. Snehalata C, Viswanathan V, Ramachandran A. Cutoff values for normal anthropometric variables in Asian Indian adults. Diabetes Care 2003;26:1380-1384. (Pubitemid 36929166)
11. Barba C, Cavalli-Sforza T, Cutter J, et al. Appropriate bodymass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157-163.
12. Devaraj S, Valleggi S, Siegel D, et al. Role of C-reactive protein in contributing to increased cardiovascular risk in metabolic syndrome. Curr Atheroscler Rep 2010;12:110-118.
13. Pfutzner A, Forst T. High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus. Diabetes Technol Ther2006;8:28-36.
14. Kimberly M, Cooper GR, Myers GL. An overview of inflammatory markers in type 2 diabetes from the perspective of the clinical chemist. Diabetes Technol Ther 2006;8:37-44.
15. Mohan V, Deepa R. Adipocytokines and the expanding 'Asian Indian phenotype'. J Assoc Physicians India 2006; 54:685-686. (Pubitemid 44371914)
16. Sadikot SM, Nigam A, Das S, et al. Diabetes India. The burden of diabetes and impaired glucose tolerance in India using the WHO 1999 criteria: Prevalence of diabetes in India study (PODIS). Diabetes Res Clin Pract 2004;66:301-307. (Pubitemid 39469376)
17. Xu Y, Zhang C, Wang N, et al. Adiponectin inhibits lymphotoxin-b receptor-mediated NF-kB signaling in human umbilical vein endothelial cells. Biochem Biophys Res Commun 2011;404:1060-1064.
18. Kazumi T, Kawaguchi A, Sakai K, et al. Young men with high-normal blood pressure have lower serum adiponectin, smaller LDL size, and higher elevated heart rate than those with optimal blood pressure. Diabetes Care 2002;5:971-976. (Pubitemid 41110480)